KRYS logo

Krystal Biotech (KRYS) EBITDA

Annual EBITDA

$109.91 M
+$201.22 M+220.36%

December 31, 2024

Summary

Performance

1-Year Change

+220.36%

3-Year Change

+265.95%

5-Year Change

+623.6%

15-Year Change

+2414.36%

KRYS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.45%
KRYS annual EBITDA is higher than 87.45% of companies in Healthcare sector

High & Low

All-time High

$109.91 M
KRYS annual EBITDA is currently at an all-time high

3-Year Low

-$116.81 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KRYS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
KRYS next annual earnings announcement has not yet been scheduled

OtherKRYSprofitabilitymetrics:

Annual Revenue

$290.51 M
KRYS annual revenue is $290.51 million

Annual Net Income

$89.16 M
KRYS annual net profit is $89.16 million

Annual EBIT

$103.19 M
KRYS annual earnings before interest & taxes is $103.19 million

Annual EPS

$3.00
KRYS annual earnings per share is $3.00

Quarterly EBITDA

$42.93 M
+$6.47 M+17.75%

December 31, 2024

Summary

Performance

3-Month Change

+17.75%

1-Year Change

+478.24%

3-Year Change

+224.98%

5-Year Change

+224.98%

KRYS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.88%
KRYS quarterly EBITDA is higher than 87.88% of companies in Healthcare sector

High & Low

All-time High

$42.93 M
KRYS quarterly EBITDA is currently at an all-time high

3-Year Low

-$36.57 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KRYS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 6, 2025
KRYS next earnings announcement is scheduled for May 6, 2025

OtherKRYSprofitabilitymetrics:

Quarterly Revenue

$91.14 M
KRYS quarterly revenue is $91.14 million

Quarterly Net Income

$45.48 M
KRYS quarterly net profit is $45.48 million

Quarterly EBIT

$41.38 M
KRYS quarterly earnings before interest & taxes is $41.38 million

Quarterly EPS

$1.52
KRYS quarterly earnings per share is $1.52

TTM EBITDA

$109.91 M
+$38.04 M+52.93%

December 31, 2024

Summary

Performance

3-Month Change

+52.93%

1-Year Change

+324.86%

3-Year Change

+194.09%

5-Year Change

+194.09%

KRYS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.45%
KRYS TTM EBITDA is higher than 87.45% of companies in Healthcare sector

High & Low

All-time High

$109.91 M
KRYS TTM EBITDA is currently at an all-time high

3-Year Low

-$136.41 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KRYS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 6, 2025
KRYS next earnings announcement is scheduled for May 6, 2025

OtherKRYSprofitabilitymetrics:

TTM Revenue

$290.51 M
KRYS TTM revenue is $290.51 million

TTM Net Income

$89.16 M
KRYS TTM net profit is $89.16 million

TTM EBIT

$103.19 M
KRYS TTM earnings before interest & taxes is $103.19 million

TTM EPS

$2.99
KRYS TTM earnings per share is $2.99

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$109.91 M
KRYS annual EBITDA is $109.91 million

Annual Net Income

$89.16 M
KRYS annual net profit is $89.16 million

Annual Interest Expense

-
KRYS annual interest expense value is unknown

Annual Income Tax

$6.20 M
KRYS annual income tax is $6.20 million

Annual D&A

$6.71 M
KRYS annual depreciation & amortization is $6.71 million

KRYS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+220.4%+478.2%+324.9%
3 y3 years+265.9%+225.0%+194.1%
5 y5 years+623.6%+225.0%+194.1%

KRYS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+194.1%at high+217.4%at high+180.6%
5 y5-yearat high+194.1%at high+217.4%at high+180.6%
alltimeall timeat high+194.1%at high+217.4%at high+180.6%

Krystal Biotech EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$109.91 M(-220.4%)
$42.93 M(+17.7%)
$109.91 M(+52.9%)
Sep 2024
-
$36.46 M(+57.9%)
$71.87 M(+566.8%)
Jun 2024
-
$23.09 M(+210.9%)
$10.78 M(-122.1%)
Mar 2024
-
$7.42 M(+51.7%)
-$48.88 M(-46.5%)
Dec 2023
-$91.32 M(-21.8%)
$4.89 M(-119.9%)
-$91.31 M(-30.1%)
Sep 2023
-
-$24.63 M(-32.7%)
-$130.56 M(-4.3%)
Jun 2023
-
-$36.57 M(+4.4%)
-$136.41 M(+6.9%)
Mar 2023
-
-$35.01 M(+1.9%)
-$127.62 M(+9.2%)
Dec 2022
-$116.81 M(+76.4%)
-$34.35 M(+12.7%)
-$116.81 M(+12.0%)
Sep 2022
-
-$30.48 M(+9.7%)
-$104.27 M(+17.7%)
Jun 2022
-
-$27.78 M(+14.7%)
-$88.60 M(+15.8%)
Mar 2022
-
-$24.21 M(+11.0%)
-$76.52 M(+15.8%)
Dec 2021
-$66.23 M(+118.5%)
-$21.81 M(+47.3%)
-$66.09 M(+22.0%)
Sep 2021
-
-$14.81 M(-5.7%)
-$54.18 M(+11.7%)
Jun 2021
-
-$15.70 M(+13.9%)
-$48.51 M(+23.8%)
Mar 2021
-
-$13.78 M(+39.3%)
-$39.17 M(+29.2%)
Dec 2020
-$30.32 M
-$9.89 M(+8.3%)
-$30.32 M(+15.5%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$9.13 M(+43.6%)
-$26.24 M(+18.5%)
Jun 2020
-
-$6.36 M(+29.1%)
-$22.15 M(+3.7%)
Mar 2020
-
-$4.93 M(-15.3%)
-$21.36 M(+1.7%)
Dec 2019
-$20.99 M(+78.3%)
-$5.82 M(+15.4%)
-$20.99 M(+8.6%)
Sep 2019
-
-$5.04 M(-9.5%)
-$19.33 M(+12.2%)
Jun 2019
-
-$5.57 M(+22.1%)
-$17.22 M(+22.3%)
Mar 2019
-
-$4.56 M(+9.7%)
-$14.08 M(+19.6%)
Dec 2018
-$11.78 M(+147.9%)
-$4.16 M(+41.7%)
-$11.78 M(+29.4%)
Sep 2018
-
-$2.93 M(+21.0%)
-$9.10 M(+10.2%)
Jun 2018
-
-$2.42 M(+7.3%)
-$8.26 M(+26.2%)
Mar 2018
-
-$2.26 M(+52.2%)
-$6.54 M(+37.8%)
Dec 2017
-$4.75 M(+316.2%)
-$1.48 M(-28.9%)
-$4.75 M(+22.3%)
Sep 2017
-
-$2.09 M(+193.3%)
-$3.88 M(+83.4%)
Jun 2017
-
-$712.00 K(+53.4%)
-$2.12 M(+50.7%)
Mar 2017
-
-$464.00 K(-25.0%)
-$1.41 M(+49.3%)
Dec 2016
-$1.14 M
-$619.00 K(+92.2%)
-$941.00 K(+192.2%)
Sep 2016
-
-$322.00 K
-$322.00 K

FAQ

  • What is Krystal Biotech annual EBITDA?
  • What is the all time high annual EBITDA for Krystal Biotech?
  • What is Krystal Biotech annual EBITDA year-on-year change?
  • What is Krystal Biotech quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Krystal Biotech?
  • What is Krystal Biotech quarterly EBITDA year-on-year change?
  • What is Krystal Biotech TTM EBITDA?
  • What is the all time high TTM EBITDA for Krystal Biotech?
  • What is Krystal Biotech TTM EBITDA year-on-year change?

What is Krystal Biotech annual EBITDA?

The current annual EBITDA of KRYS is $109.91 M

What is the all time high annual EBITDA for Krystal Biotech?

Krystal Biotech all-time high annual EBITDA is $109.91 M

What is Krystal Biotech annual EBITDA year-on-year change?

Over the past year, KRYS annual EBITDA has changed by +$201.22 M (+220.36%)

What is Krystal Biotech quarterly EBITDA?

The current quarterly EBITDA of KRYS is $42.93 M

What is the all time high quarterly EBITDA for Krystal Biotech?

Krystal Biotech all-time high quarterly EBITDA is $42.93 M

What is Krystal Biotech quarterly EBITDA year-on-year change?

Over the past year, KRYS quarterly EBITDA has changed by +$35.51 M (+478.24%)

What is Krystal Biotech TTM EBITDA?

The current TTM EBITDA of KRYS is $109.91 M

What is the all time high TTM EBITDA for Krystal Biotech?

Krystal Biotech all-time high TTM EBITDA is $109.91 M

What is Krystal Biotech TTM EBITDA year-on-year change?

Over the past year, KRYS TTM EBITDA has changed by +$158.79 M (+324.86%)